Loading organizations...
Loading organizations...
Recombinant human collagen biomaterial for wound repair and cosmetology.
Xiangya Biopharma has raised $13.8M across 1 funding round.
Xiangya Biopharma has raised $13.8M in total across 1 funding round.
Xiangya Biopharma has raised $13.8M in total across 1 funding round.
Xiangya Biopharma has raised $13.8M across 1 funding round. Most recently, it raised $13.8M Series A in May 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 27, 2024 | $13.8M Series A |